Related Experiment Video
Updated: Apr 6, 2026
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Invasive candidiasis in non neutropenic critically ill - need for region-specific management guidelines
Armin Ahmed1, Afzal Azim1, A K Baronia1
1Department of Critical Care Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Abstract:
Use of antifungal agents has increased over past few decades. A number of risk factors such as immunosuppression, broad spectrum antibiotics, dialysis, pancreatitis, surgery, etc., have been linked with the increased risk of invasive candidiasis. Though there are various guidelines available for the use of antifungal therapy, local/regional epidemiology plays an important role in determining the appropriate choice of agent in situations where the offending organism is not known (i.e. empirical, prophylactic or preemptive therapy). Developing countries like India need to generate their own epidemiological data to facilitate appropriate use of antifungal therapy. In this article, the authors have highlighted the need for region-specific policies/guidelines for treatment of invasive candidiasis. Currently available Indian literature on candidemia epidemiology has also been summarized here.
Insights
Antifungal use is rising, increasing invasive candidiasis risk. Region-specific Indian epidemiological data is crucial for guiding empirical antifungal therapy and developing effective treatment guidelines.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Pharmacology
Background:
- Antifungal agent use has significantly increased globally over recent decades.
- Invasive candidiasis risk is associated with factors like immunosuppression, broad-spectrum antibiotics, and medical procedures.
- Existing antifungal therapy guidelines may not fully address regional variations in epidemiology.
Purpose of the Study:
- To emphasize the need for region-specific policies and guidelines for invasive candidiasis treatment in India.
- To summarize existing Indian literature on candidemia epidemiology.
- To advocate for the generation of local epidemiological data to inform antifungal therapy choices.
Main Methods:
- Review of current Indian literature on candidemia epidemiology.
- Analysis of risk factors associated with invasive candidiasis.
- Discussion on the role of local epidemiology in empirical, prophylactic, and preemptive antifungal therapy.
Main Results:
- Increased use of antifungals correlates with higher invasive candidiasis incidence.
- Specific patient factors (immunosuppression, antibiotics, dialysis, etc.) are linked to increased risk.
- A gap exists in region-specific epidemiological data for India.
Conclusions:
- Developing countries, particularly India, require tailored epidemiological data for appropriate antifungal use.
- Region-specific guidelines are essential for managing invasive candidiasis, especially when pathogen identification is pending.
- Local data generation is key to optimizing empirical, prophylactic, and preemptive antifungal strategies.
